Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
Werewolf Therapeutics Inc (NASDAQ: HOWL) closed the day trading at $0.57 down -0.56% from the previous closing price of $0.57. In other words, the price has decreased by -$0.56 from its previous closing price. On the day, 0.73 million shares were traded. HOWL stock price reached its highest trading level at $0.5737 during the session, while it also had its lowest trading level at $0.5349.
Ratios:
For a better understanding of HOWL, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.87 and its Current Ratio is at 3.87. In the meantime, Its Debt-to-Equity ratio is 1.26 whereas as Long-Term Debt/Eq ratio is at 1.01.
On April 03, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $12.
On August 24, 2023, Wedbush started tracking the stock assigning a Outperform rating and target price of $9.Wedbush initiated its Outperform rating on August 24, 2023, with a $9 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 12 ’26 when EVNIN LUKE sold 58,980 shares for $0.57 per share. The transaction valued at 33,619 led to the insider holds 2,309,869 shares of the business.
EVNIN LUKE sold 24,678 shares of HOWL for $15,054 on Jan 09 ’26. The Director now owns 2,368,849 shares after completing the transaction at $0.61 per share. On Jan 08 ’26, another insider, EVNIN LUKE, who serves as the Director of the company, sold 7,716 shares for $0.63 each. As a result, the insider received 4,861 and left with 2,393,527 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HOWL now has a Market Capitalization of 27735870 and an Enterprise Value of -675129.
Stock Price History:
The Beta on a monthly basis for HOWL is 0.77, which has changed by -0.5863309 over the last 52 weeks, in comparison to a change of 0.1726681 over the same period for the S&P500. Over the past 52 weeks, HOWL has reached a high of $2.38, while it has fallen to a 52-week low of $0.56. The 50-Day Moving Average of the stock is -36.28%, while the 200-Day Moving Average is calculated to be -51.62%.
Shares Statistics:
Over the past 3-months, HOWL traded about 728.96K shares per day on average, while over the past 10 days, HOWL traded about 578960 shares per day. A total of 47.27M shares are outstanding, with a floating share count of 39.30M. Insiders hold about 19.04% of the company’s shares, while institutions hold 29.83% stake in the company. Shares short for HOWL as of 1767139200 were 2118631 with a Short Ratio of 2.91, compared to 1764288000 on 1025313. Therefore, it implies a Short% of Shares Outstanding of 2118631 and a Short% of Float of 5.9899997.
Earnings Estimates
Werewolf Therapeutics Inc (HOWL) is currently under the scrutiny of 4.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.33, with high estimates of -$0.27 and low estimates of -$0.4.
Analysts are recommending an EPS of between -$1.4 and -$1.53 for the fiscal current year, implying an average EPS of -$1.48. EPS for the following year is -$1.25, with 4.0 analysts recommending between -$0.89 and -$1.62.
